Cognitive Health Startup Ivory raises fresh capital to strengthen deep tech offerings

▴ Ivory onboards new investors
The company plans to strengthen its product and clinical capabilities with this new fund raise.

Mumbai, India, 15th April 2026: Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical, and IP capabilities.

The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched by Ministry of Social Justice and Empowerment (MoSJE) (selection partners for Startups) and managed by IFCI Venture, a subsidiary of IFCI Limited and Small Industries Development Bank of India (SIDBI). The investment reflects growing institutional interest in preventive health platforms that are building for scale and real-world impact.

Ivory is addressing a critical gap in India’s healthcare ecosystem by making cognitive screening accessible, trackable, and part of routine preventive care. While millions of Indians actively monitor physical health markers, cognitive health remains largely unmeasured, with a significant proportion of impairments going undiagnosed.

With this capital, the company plans to further strengthen its technology stack, expand clinical capabilities, and enhance its product offerings particularly in building scalable, evidence-based solutions that integrate seamlessly across both consumer and clinical workflows.

Rahul Krishnan, Co-founder & CPO, Ivory, said “Preventive healthcare in India is at an inflection point, but cognitive health has largely remained outside this shift. Our focus at Ivory is to make brain health measurable and actionable, much like other key health biomarkers. This round allows us to deepen our clinical and product capabilities, while continuing to build a scalable, digital-first layer for cognitive screening across both consumers and healthcare systems.”

Anish Babu, Managing Director, IFCI Venture, said “We are seeing strong momentum in startups building for preventive healthcare and large-scale health impact. Ivory is addressing a significant unmet need in cognitive health through a clinically grounded and technology-led approach. We are pleased to support their journey as they work towards making early cognitive screening more accessible and mainstream in India.”

Furthermore, this investment reflects broader institutional support for early-stage startups focused on public health impact, with organizations like IFCI Venture and initiatives supported by the Ministry of Social Justice and Empowerment playing an important role in enabling innovation in critical healthcare segments for Silver Economy in India.

The company has also been expanding its partnerships across the healthcare ecosystem. Most recently, Ivory collaborated with Metropolis Healthcare, a multinational chain of diagnostic labs, to launch the TruHealth Mind & Body package, an integrated preventive health offering that combines pathology diagnostics with neuroscience-based cognitive assessments.

This offering brings together physical and cognitive health into a single screening experience, enabling individuals to track key cognitive functions such as memory, attention, and executive function alongside traditional health markers, reflecting a more holistic approach to preventive care.

Ivory had made a successful appearance on Shark Tank India last year. Apart from this, Ivory has previously raised $1 million in a round co-led by IIM-A Ventures & Capital A. The company also counts 1Crowd, TDV Partners and Stanford Angels among its investors.

As part of its broader roadmap, Ivory continues to build towards making cognitive health a routine, trackable metric, bridging the gap between early detection and proactive intervention in India’s evolving preventive healthcare landscape.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026